Publications by authors named "Xuexia Zhou"

Claim this Profile
C
Correction to "Improved Antiglioblastoma Activity and BBB Permeability by Conjugation of Paclitaxel to a Cell-Penetrative MMP-2-Cleavable Peptide".
Dan Hua, Lida Tang, Weiting Wang, Shengan Tang, Lin Yu, Xuexia Zhou

Adv Sci (Weinh)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia-induced S100A10 promotes glioblastoma malignancy and chemoresistance by activating PI3K-AKT signaling pathway.
Qingqing Yang, Yunlan Xi, Xuewei Huang, Wenzhe An, Cuiyun Sun, Xuexia Zhou

Funct Integr Genomics· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Comprehensive Analysis of the Expression, Prognosis and Function of TRAF Family Proteins 
in NSCLC].
Yixuan Wang, Qiang Chen, Yaguang Fan, Shuqi Tu, Yang Zhang, Xuexia Zhou

Zhongguo Fei Ai Za Zhi· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZNRF2 is essential for gliomagenesis through orchestrating glycolysis and acts as a promising therapeutic target in glioma.
Yunlan Xi, Qingqing Yang, Yixuan Wang, Wenzhe An, Xuewei Huang, Xuexia Zhou

J Transl Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Genetic analysis and prenatal diagnosis of a Chinese pedigree affected with Complete androgen insensitivity syndrome due to a novel variant of AR gene].
Fanrong Meng, Xiaozhou Li, Yunfang Shi, Duan Ju, Xiuyan Wang, Xuexia Zhou

Zhonghua Yi Xue Yi Chuan Xue Za Zhi· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Recruitment of LEF1 by Pontin chromatin modifier amplifies TGFBR2 transcription and activates TGFβ/SMAD signalling during gliomagenesis.
Xuexia Zhou, Xuebing Li, Run Wang, Dan Hua, Cuiyun Sun

Cell Death Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prenatal diagnosis of a case with Congenital myasthenic syndrome due to compound heterozygous variants of SCN4A gene].
Fanrong Meng, Yunfang Shi, Duan Ju, Xiuyan Wang, Haiwei Dong, Xiaozhou Li, Xuexia Zhou

Zhonghua Yi Xue Yi Chuan Xue Za Zhi· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of SRSF10 as a promising prognostic biomarker with functional significance among SRSFs for glioma.
Wenzhe An, Qingqing Yang, Yunlan Xi, Hongli Pan, Hua Huang, Xuexia Zhou

Life Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wilms' tumour gene 1 (WT1) enhances non-small cell lung cancer malignancy and is inhibited by microRNA-498-5p.
Xuebing Li, Wenzhe An, Hongli Pan, Yaguang Fan, Hua Huang, Xuexia Zhou

BMC Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Wilms' tumour gene 1 (WT1) enhances non-small cell lung cancer malignancy and is inhibited by microRNA-498-5p.
Xuebing Li, Wenzhe An, Hongli Pan, Yaguang Fan, Hua Huang, Xuexia Zhou

BMC Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The miR-29 family members induce glioblastoma cell apoptosis by targeting cell division cycle 42 in a p53-dependent manner.
Cuijuan Shi, Wenjun Luo, Cuiyun Sun, Lin Yu, Xuexia Zhou

Eur J Clin Invest· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recruitment of LEF1 by Pontin chromatin modifier amplifies TGFBR2 transcription and activates TGFβ/SMAD signalling during gliomagenesis.
Xuexia Zhou, Xuebing Li, Run Wang, Dan Hua, Cuiyun Sun

Cell Death Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary mucoepidermoid carcinoma: A clinicopathological study of 45 patients.
Wang Shen, Tao Yang, Yaguang Fan, Xuebing Li, Cheng Ai, Xuexia Zhou

Thorac Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Eucalyptal A inhibits glioma by rectifying oncogenic splicing of MYO1B mRNA via suppressing SRSF1 expression" [Eur. J. Pharmacol. (2021) 890 173669].
Dan Hua, Qian Zhao, Yang Yu, Huan Yu, Lin Yu, Xuexia Zhou

Eur J Pharmacol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ATPase Pontin is a key cell cycle regulator by amplifying E2F1 transcription response in glioma.
Run Wang, Xuebing Li, Cuiyun Sun, Lin Yu, Dan Hua, Xuexia Zhou

Cell Death Dis· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Antiglioblastoma Activity and BBB Permeability by Conjugation of Paclitaxel to a Cell-Penetrative MMP-2-Cleavable Peptide.
Dan Hua, Lida Tang, Weiting Wang, Shengan Tang, Lin Yu, Xuexia Zhou

Adv Sci (Weinh)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eucalyptal A inhibits glioma by rectifying oncogenic splicing of MYO1B mRNA via suppressing SRSF1 expression.
Dan Hua, Qian Zhao, Yang Yu, Huan Yu, Lin Yu, Xuexia Zhou

Eur J Pharmacol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The RNA-binding protein SRSF1 is a key cell cycle regulator via stabilizing NEAT1 in glioma.
Xuexia Zhou, Xuebing Li, Lin Yu, Run Wang, Dan Hua

Int J Biochem Cell Biol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.
Lin Yu, Jinling Xu, Jing Liu, Huibian Zhang, Cuiyun Sun, Xuexia Zhou

Neuro Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B.
Xuexia Zhou, Run Wang, Xuebing Li, Lin Yu, Dan Hua

J Clin Invest· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-135a-5p Functions as a Glioma Proliferation Suppressor by Targeting Tumor Necrosis Factor Receptor-Associated Factor 5 and Predicts Patients' Prognosis.
Wenjun Luo, Cuiyun Sun, Junhu Zhou, Qian Wang, Lin Yu, Xuexia Zhou

Am J Pathol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-29s function as tumor suppressors in gliomas by targeting TRAF4 and predict patient prognosis.
Cuijuan Shi, Chun Rao, Cuiyun Sun, Lin Yu, Xuexia Zhou, Junhu Zhou

Cell Death Dis· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-361-5p inhibits glioma migration and invasion by targeting SND1.
Jing Liu, Jie Yang, Lin Yu, Chun Rao, Qian Wang, Xuexia Zhou

Onco Targets Ther· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quaking-5 suppresses aggressiveness of lung cancer cells through inhibiting β-catenin signaling pathway.
Xuexia Zhou, Xuebing Li, Cuiyun Sun, Cuijuan Shi, Dan Hua, Qinghua Zhou

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patients.
Cuijuan Shi, Linlin Ren, Cuiyun Sun, Lin Yu, Xiuwu Bian, Xuexia Zhou

Br J Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis